Biospace
Published September 15, 2026 · Updated September 16, 2026
BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim ...
Read the full story at Biospace
HT9425-24-1-0113. Opinions, interpretations, conclusions and recommendations in this press release are those of the author and are not necessarily.
Surfaced by this Google Alert
- Psychedelic press release
